Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clopidogrel response variability and the advent of personalised antiplatelet therapy. A bench to bedside journey.

Thrombosis and haemostasis - 1 Aug 2011

Gurbel Paul A, Tantry Udaya S

Abstract excerpt

Platelet-mediated thrombosis is a dreaded clinical event and is the primary cause of acute coronary syndromes and post-percutaneous intervention (PCI) ischaemic events. There has been a long standing interest in the ex vivo quantification of platelet reactivity to assess the risk of thrombosis. Early studies demonstrated platelet activation and heightened platelet reactivity in acute coronary syndromes and after...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Coronary Syndrome
Share to Angioplasty, Balloon, Coronary

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Clopidogrel

Share to Platelet Aggregation Inhibitors

Share to Receptors, Purinergic P2Y12

Share to Stents

Share to Ticlopidine

Share to Translational Research, Biomedical

Source

Identifiers

PMID: 21713326
DOI: 10.1160/TH11-03-0167

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clopidogrel response variability and the advent of personalised antiplatelet therapy. A bench to bedside journey.PMID 21713326Read ↗

High platelet reactivity and clinical outcome - fact and fiction.Semantic proximity Read ↗

Tailoring antiplatelet therapy: a step toward individualized therapy to improve clinical outcome?Semantic proximity Read ↗

Latest evidence in personalized antiplatelet therapy in patients with acute coronary syndromes undergoing percutaneous coronary intervention.Semantic proximity Read ↗

Interindividual variability in the efficacy of oral antiplatelet drugs: definitions, mechanisms and clinical importance.Semantic proximity Read ↗

Clopidogrel response variability is associated with endothelial dysfunction in coronary artery disease patients receiving dual antiplatelet therapy.Semantic proximity Read ↗

Genetically Determined Platelet Reactivity and Related Clinical Implications.Semantic proximity Read ↗

Response variability to P2Y12 receptor inhibitors: expectations and reality.Semantic proximity Read ↗

Clinical, genetic and confounding factors determine the dynamics of the in vitro response/non response to clopidogrelSemantic proximity Read ↗

P2Y12 receptor inhibitor resistance and coronary artery disease: a bench to bedside primer for cardiovascular specialists.Semantic proximity Read ↗

Recent developments in the use of antiplatelet agents to prevent cardiovascular events.Semantic proximity Read ↗

Optimisation of anti-platelet therapy in acute coronary syndromesSemantic proximity Read ↗

Influence of genetic polymorphisms on platelet function, response to antiplatelet drugs and clinical outcomes in patients with coronary artery disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.